Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MDxHealth SA
MDXH | US
0.57
USD-0.03
-5.68%
MDXH | US
Loading StockChartView...
About MDxHealth SA
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
05/06/2026
Close
0.57
Open
0.61
High
0.61
Low
0.51
MDxHealth SA a commercial-stage precision diagnostics company provides urologic solutions in the United States Europe and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx a non-invasive urine test; and ConfirmMDx an epigenetic test which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal Belgium.
View LessMDXH | US
Risk
172.1
Sharpe
-0.99
Luna's Score
42/100
Recommendation
Sell
Luna says (MDXH | US)
What's Working
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
65.8%1 month
172.1%3 months
112.9%6 months
90.9%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.55
Debt to equity
-6.43
Debt to assets
0.43
Ent. to EBITDA
-2.73
Ent. to rev.
1.61
PEG
-
Other Fundamentals
EBITDA
-18.62M
MarketCap
26.76M
MarketCap(USD)
26.76M
Div. yield
-
Op. margin
-32.38
Erngs. growth
-
Rev. growth
32.30
Ret. on equity
-457.29
Short ratio
0.34
Short perc.
0.11
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.33
Range1M
1.62
Range3M
3.04
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.75
Price X volume
571.32K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -2.73 | 12.67 | Cheaper |
| Ent. to Revenue | 1.61 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 3.55 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 112.89 | 59.59 | Riskier |
| Debt to Equity | -6.43 | -14.36 | Expensive |
| Debt to Assets | 0.43 | 0.34 | Expensive |
| Market Cap | 26.76M | 13.71B | Emerging |
